TruTrace Technologies (CSE: TTT) CEO Robert Galarza sat down with Steve Darling from Proactive Vancouver to discuss their recent deal with Sigma Analytical Services. Galarza talks about how they plan on integrating their technology with what Sigma has already.
Galarza also talked with Proactive about their deal with Deloitte and as expected, the doors its opened tor TruTrace.
Price: 0.06 CAD
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of named herein, including the promotion by the Company of in any Content on the Site, the Company receives from said issuer annual cash...
FOR OUR FULL DISCLAIMER CLICK HERE
TruTrace Technologies (CSE: TTT- OTCQB: TTTSF) CEO Robert Galarza joined Steve Darling from Proactive to bring news the company has announced that it has signed a letter of intent with Georgia-based PharmaCentra to support a clinical trial ecosystem built on standardized protocols and testing of...
Prev article
